Scholars@Duke publication: Six-week outcomes after pegaptanib.

Six-week outcomes after pegaptanib.

Publication , Other

Schuman, S; Rogers, AH; Duker, JS; Reichel, E; Baumal, CR

Published in: Ophthalmology

March 2006

Published version (DOI) Link to item

Duke Scholars

Author Stefanie Gail Schuman Ophthalmology, Vitreoretinal Diseases & Surgery

Published In

Ophthalmology

DOI

10.1016/j.ophtha.2005.12.016

EISSN

1549-4713

Publication Date

March 2006

Volume

113

Issue

Start / End Page

501

Location

United States

Related Subject Headings

Vitreous Body
Visual Acuity
Treatment Outcome
Tomography, Optical Coherence
Time Factors
Ophthalmology & Optometry
Macular Degeneration
Humans
Aptamers, Nucleotide
3212 Ophthalmology and optometry

Citation

APA

Chicago

ICMJE

MLA

NLM

Schuman, S., Rogers, A. H., Duker, J. S., Reichel, E., & Baumal, C. R. (2006). Six-week outcomes after pegaptanib. Ophthalmology. United States. https://doi.org/10.1016/j.ophtha.2005.12.016

Schuman, Stefanie, Adam H. Rogers, Jay S. Duker, Elias Reichel, and Caroline R. Baumal. “Six-week outcomes after pegaptanib.” Ophthalmology, March 2006. https://doi.org/10.1016/j.ophtha.2005.12.016.

Schuman S, Rogers AH, Duker JS, Reichel E, Baumal CR. Six-week outcomes after pegaptanib. Vol. 113, Ophthalmology. 2006. p. 501.

Schuman, Stefanie, et al. “Six-week outcomes after pegaptanib.” Ophthalmology, vol. 113, no. 3, Mar. 2006, p. 501. Pubmed, doi:10.1016/j.ophtha.2005.12.016.

Schuman S, Rogers AH, Duker JS, Reichel E, Baumal CR. Six-week outcomes after pegaptanib. Ophthalmology. 2006. p. 501.

Published In

Ophthalmology

DOI

10.1016/j.ophtha.2005.12.016

EISSN

1549-4713

Publication Date

March 2006

Volume

113

Issue

Start / End Page

501

Location

United States

Related Subject Headings

Vitreous Body
Visual Acuity
Treatment Outcome
Tomography, Optical Coherence
Time Factors
Ophthalmology & Optometry
Macular Degeneration
Humans
Aptamers, Nucleotide
3212 Ophthalmology and optometry